- Home
- PRLD vs KORE Comparison
PRLD vs KORE Comparison
Compare PRLD & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRLD | KORE |
|---|---|---|
| Founded | 2016 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 78.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRLD | KORE |
|---|---|---|
| Price | $2.78 | $4.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $4.00 | ★ $5.00 |
| AVG Volume (30 Days) | ★ 534.1K | 46.9K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $10,500,000.00 | ★ $285,408,000.00 |
| Revenue This Year | N/A | $1.26 |
| Revenue Next Year | N/A | $7.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 250.00 | 0.06 |
| 52 Week Low | $0.61 | $1.66 |
| 52 Week High | $4.22 | $4.88 |
Technical Indicators
Market Signals| Indicator | PRLD | KORE |
|---|---|---|
| Relative Strength Index (RSI) | 62.95 | 61.91 |
| Support Level | $2.37 | $4.16 |
| Resistance Level | $3.00 | $4.50 |
| Average True Range (ATR) | 0.28 | 0.23 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 78.39 | 88.00 |
Price Performance
Historical ComparisonAbout PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.